COVAXIN

EUA to Corbevax for 12-18 Age Group

A vaccine manufacturer based in Hyderabad, Biological E has received emergency use authorization (EUA) from the drug regulator of India for its Covid-19 vaccine for children aged 12 to 18. Overview: Biological E’s Corbevax vaccine was earlier approved by the ..

Month: 

Category: 

Bharat Biotech Nasal Booster Trials

The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the ..

Month: 

Category: 

Conditional market approval for Covaxin, Covishield

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional ..

Month: 

Category: 

Commemorative Postal Stamp on COVID-19 vaccine

The Ministry of Health and Family Welfare recently released commemorative postal stamp on COVID-19 vaccine. The stamp was launched to mark the first anniversary of the National COVID Vaccination Programme or the COVID vaccination drive. Design of the stamp The ..

Month: 

Category: 

Precautionary vaccine jabs in India

The Government of India is to provide third dose of vaccine. This third dose has been named “precaution dose” or booster dose. About the precaution dose The health care workers, comorbid patients (people with severe medical conditions) and frontline workers ..

Month: 

Category: 

India set to touch 100 crore Covid vaccination mark

India crossed another significant milestone in its fight against the covid-19 pandemic on October 21, 2021. It touched the mark of 100 crore Covid vaccinations including the first as well as second doses. Key Points On the other hand, India ..

Month: